In patients receiving thereapy with high biotin doses (i.e.> 5mg/day), no sample should be taken until at least 8 hours after the last biotin administration.
Interference was observed from Rheumatoid factor above concentrations up to 7000 U/mL.
False negative results can occur in patients with hypergammaglobulinemia.